StockData
Arcutis Biotherapeutics, Inc. logo

Arcutis Biotherapeutics, Inc. (ARQT) stock

ARQTNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 11/30403% above fair value
$27.33+0.18 (+0.66%)

Close on Nov 17, 2026Market cap $3.44BP/E 124.2Yield –

Arcutis Biotherapeutics price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Arcutis Biotherapeutics's price to book ratio was 16.2× on Nov 11, 2026, against 23.3× a year earlier. Over the last 5 years it ranged from 1.7× to 23.3×, with a median of 7.1×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 202616.2×−5.9
2025Dec 31, 202522.1×+11.7
2024Dec 31, 202410.4×+6.1
2023Dec 29, 20234.3×+0.9
2022Dec 30, 20223.3×+0.5
2021Dec 31, 20212.9×−3.3
2020Dec 31, 20206.1×–

More Arcutis Biotherapeutics figures

See a number that looks wrong?